Kymera Therapeutics KYMR
$115.31 −$4.08 (-3.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $124.06 +7.59%
Open$117.89
Prev close$119.39
Day range$114.40 – $119.60
Volume1.28M
Market cap$9.84B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts13
Average target$150.69+30.7% vs. price
- Buy 100%
Low $129.00Now $115.31Avg $150.69High $180.00
Recent rating changes
The last 20 actions on file set price targets from $129.00 to $180.00, averaging $149.40.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 3 Nov 2026 | CCORF | BUY | $129.00 |
| 2 Nov 2026 | Barclays | BUY | $170.00 |
| 1 Nov 2026 | BTIG | BUY | $139.00 |
| 30 Oct 2026 | CCORF | BUY | $129.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $150.00 |
| 30 Oct 2026 | Barclays | BUY | $170.00 |
| 29 Oct 2026 | Wells Fargo | BUY | $151.00 |
| 29 Oct 2026 | Raymond James | BUY | $144.00 |
| 29 Oct 2026 | BTIG | BUY | $139.00 |
| 29 Oct 2026 | Citi | BUY | $150.00 |
| 28 Oct 2026 | Guggenheim | BUY | $170.00 |
| 15 Oct 2026 | Wells Fargo | BUY | $151.00 |
| 15 Oct 2026 | Citi | BUY | $150.00 |
| 8 Oct 2026 | Raymond James | BUY | $140.00 |
| 5 Oct 2026 | Citi | BUY | $150.00 |
| 28 Sep 2026 | J.P. Morgan | BUY | $140.00 |
| 23 Sep 2026 | Piper Sandler | BUY | $140.00 |
| 22 Sep 2026 | Stifel | BUY | $152.00 |
| 14 Sep 2026 | BofA Securities | BUY | $144.00 |
| 10 Sep 2026 | Wolfe Research | BUY | $180.00 |
No comments yet — be the first to weigh in on KYMR.
Sign in to join the discussion.